4//SEC Filing
Lo Andrew 4
Accession 0000950170-25-089674
CIK 0001743881other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 7:13 PM ET
Size
8.1 KB
Accession
0000950170-25-089674
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Award
Common Stock
2025-06-20+6,589→ 54,688 total - Award
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 totalExercise: $41.73Exp: 2035-06-19→ Common Stock (8,425 underlying)
Holdings
- 105,583(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
Common Stock
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001679076
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 7:13 PM ET
- Size
- 8.1 KB